New FDA Guidance Would Deny Doctors Information They Need In Prescribing Biosimilar Medicines

The Food and Drug Administration appears to believe it knows better than physicians do what information they need to best treat their patients. That is the logical conclusion drawn from draft guidance the agency recently released on what should and should not be included on the labels of the latest generation of pharmaceuticals—a new...

Prescription drug price controls pose lethal problems

The Democratic primaries may be contentious, but both candidates agree on one point: government fiat must rein in prescription drug prices. Hillary Clinton proposes caps on drug prices and a mandate that pharmaceutical companies spend a preset percentage of revenues on research and development. She’d confiscate any excess to subsidize public biomedical research institutions...

The Folly of Targeting Big Pharma

An unfortunate refrain among Democratic presidential hopefuls is that rapacious pharmaceutical and biotech companies are driving up the cost of essential medications, bankrupting the health-care system, and depriving sick Americans of treatment. Hillary Clintonhas honed her message to a nice sound bite: Drug companies that charge excessively high prices “are making a fortune off...